These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10912964)

  • 41. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 42. [Isoimmunization to Kell factor, during pregnancy].
    Krug A; Bianchi R; Cornejo A; Farias S; Fuentes L
    Rev Chil Obstet Ginecol; 1988; 53(4):198-200. PubMed ID: 3155245
    [No Abstract]   [Full Text] [Related]  

  • 43. [Anti-K antibodies in pregnant women and genotyping of K antigen in foetuses].
    Zupańska B; Nowaczek-Migas M; Michalewska B; Wielgoś M; Orzińska A
    Ginekol Pol; 2008 Jun; 79(6):410-4. PubMed ID: 18652128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Rapid and severe development of fetal hemolytic disease due to anti-Kell antibodies].
    Frère MC; Schaaps JP; Thoumsin H; Retz MC; Rif J; Rigo J; De Cortis T; Lambotte R; Senterre J; Sondag-Thull D
    Rev Med Liege; 1995 Feb; 50(2):63-6. PubMed ID: 7899747
    [No Abstract]   [Full Text] [Related]  

  • 45. Anti-Kell in pregnancy.
    Leggat HM; Gibson JM; Barron SL; Reid MM
    Br J Obstet Gynaecol; 1991 Feb; 98(2):162-5. PubMed ID: 2004052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amniotic fluid insulin and glucagon in normal pregnancy and pregnancy complicated by rhesus isoimmunization.
    Gerlini G; Fallucca F; Pachi' A; Bresadola M; Ossicini C; Russo A; Sbraccia C
    Br J Obstet Gynaecol; 1977 Nov; 84(11):819-23. PubMed ID: 412514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New possibilities in diagnosing hemolytic disease of newborn infants].
    Fischer K; Poschmann A; Grundmann A; Asmussen S
    Beitr Infusionsther; 1992; 30():431-5. PubMed ID: 1284753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prenatal typing of Rh- and Kell- blood group system antigens].
    Faas BH; Maaskant-van Wijk PA; Beuling EA; Overbeeke MA; van der Schoot CE; Christiaens GC
    Ned Tijdschr Geneeskd; 1999 Sep; 143(36):1804-7. PubMed ID: 10526582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Examination of the amniotic fluid in pregnancies complicated by neonatal hemolytic disease].
    Breborowicz H; Baraniecka K; Wedrychowicz J; Breborowicz A
    Ginekol Pol; 1968 Jan; 39(1):17-21. PubMed ID: 5665487
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical consequences of the extremely rare anti-PP1Pk isoantibodies in pregnancy: a case series and review of the literature.
    Di Ciaccio P; Cutts B; Alahakoon TI; Dennington PM; Soo LA; Curnow J
    Vox Sang; 2021 May; 116(5):591-600. PubMed ID: 33326620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The predictive value of maternal serum testing for detection of fetal anemia in red blood cell alloimmunization.
    Moise KJ; Perkins JT; Sosler SD; Brown SJ; Saade G; Carpenter RJ; Thorp JA; Ludomirski A; Wilkins IA; Grannum PA
    Am J Obstet Gynecol; 1995 Mar; 172(3):1003-9. PubMed ID: 7892839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diagnostic and therapeutic possibilities in incompatibility processes].
    Kozlowski P
    Gynakologe; 1990 Jun; 23(3):172-7. PubMed ID: 2117563
    [No Abstract]   [Full Text] [Related]  

  • 54. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ABO incompatibility--when is antenatal testing indicated?
    Beischer NA
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):315. PubMed ID: 9325514
    [No Abstract]   [Full Text] [Related]  

  • 56. [Test for blood group incompatibility in pregnancy].
    Okubo M; Tate A; Maeda H; Suzuki M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():803-6. PubMed ID: 20942195
    [No Abstract]   [Full Text] [Related]  

  • 57. [Serologic incompatibility and family planning].
    Matýsek P; Ungerová A; Cuprová M; Muchová M
    Cesk Gynekol; 1988 Aug; 53(7):497-9. PubMed ID: 3168017
    [No Abstract]   [Full Text] [Related]  

  • 58. The outcome of pregnancy in Kell alloimmunisation.
    Grant SR; Kilby MD; Meer L; Weaver JB; Gabra GS; Whittle MJ
    BJOG; 2000 Apr; 107(4):481-5. PubMed ID: 10759266
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN; Moise KJ
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
    van Dijk BA; Hirasing RA; Overbeeke MA
    Ned Tijdschr Geneeskd; 1999 Jul; 143(28):1465-9. PubMed ID: 10443262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.